This protocol is judged by an institutional evaluation board, an impartial team that critiques any scientific trials involving people. If a review consists of a Routine I drug, as soon as the board approves the protocol as ethical, the scientists have to submit an application for an investigational new drug (IND) selection through the FDA.“It’